quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:23:00·811d
SECFiling
Vallon Pharmaceuticals Inc. logo

Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

VLON· Vallon Pharmaceuticals Inc.
Health Care
Original source

Companies

  • VLON
    Vallon Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Nov 22UpdateHC Wainwright & Co.$12.00

Related

  • SEC811d
    SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
  • SEC811d
    SEC Form 424B4 filed by Vallon Pharmaceuticals Inc.
  • SEC812d
    SEC Form EFFECT filed by Vallon Pharmaceuticals Inc.
  • SEC813d
    SEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)
  • SEC814d
    SEC Form S-1/A filed by Vallon Pharmaceuticals Inc. (Amendment)
  • SEC814d
    SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
  • SEC814d
    Vallon Pharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
  • SEC825d
    SEC Form 424B3 filed by Vallon Pharmaceuticals Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022